First-In-Human Study of AK1320 Encapsulated Microspheres (AK1320 MS)

NCT04483297 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

30

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Degenerative Spondylolisthesis
Spinal Stenosis

Interventions

DRUG: AK1320 MS
OTHER: Control

Sponsor

Asahi Kasei Therapeutics Corporation

Collaborators

[object Object]